Microbix Biosystems IncTSX:MBXView on OTCQX International
- LAST PRICE0.3200
- TODAY'S CHANGE (%)-0.0150 (-4.4776%)
- Bid / Lots0.3200/ 1
- Ask / Lots0.3300/ 2
- Open / Previous Close0.3300 / 0.3350
- Day Range
- 52 Week Range
- Volume82,480
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MBX |
|---|---|---|
| 09:32 ET | 7000 | 0.325 |
| 10:32 ET | 1000 | 0.33 |
| 11:31 ET | 29000 | 0.325 |
| 11:33 ET | 25000 | 0.32 |
| 11:36 ET | 20000 | 0.32 |
Yesterday
Microbix Collaborator Introduces New Lab Accreditation Program, from 7:00AM ET on Thursday Apr 25, 2024 by Dow Jones
7:00AM ET on Thursday Apr 25, 2024 by Dow Jones
Apr 11, 2024
Microbix Presenting at the 2024 Bloom Burton Conference, from 7:00AM ET on Thursday Apr 11, 2024 by Dow Jones
7:00AM ET on Thursday Apr 11, 2024 by Dow Jones
Apr 1, 2024
Microbix Announces Annual and Special Meeting Voting Results, from 7:00AM ET on Monday Apr 01, 2024 by Dow Jones
7:00AM ET on Monday Apr 01, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Microbix Biosystems Inc | 46.0M | 11.8x | --- |
Avicanna Inc | 31.3M | -3.4x | --- |
Immunoprecise Antibodies Ltd | 31.4M | -3.1x | --- |
Ceapro Inc | 18.7M | -7.0x | --- |
Numinus Wellness Inc | 25.3M | -0.7x | --- |
MustGrow Biologics Corp | 54.4M | -80.1x | --- |
Company Information
Microbix Biosystems Inc. is a Canada-based life science company, which develops and commercializes biological and technological solutions for human health and wellbeing. The Company manufactures a wide range of critical biological materials for the global diagnostics industry, mainly antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. It operates through two segments: the development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and the development and commercialization of products or technologies such as Kinlytic. Its Kinlyti urokinase is a biologic thrombolytic drug used to treat blood clots.
Contact Information
- Headquarters
- 265 Watline AvenueMISSISSAUGA, ON, Canada L4Z 1P3
- Phone
- 905-361-8910
- Fax
- 905-361-8910
Executives
- Independent Chairman of the Board
- Martin Marino
- President, Chief Executive Officer, Director
- Cameron Groome
- Chief Financial Officer
- James Currie
- Chief Operating Officer
- Kenneth Hughes
- Senior Vice President - Sales and Business Development
- Phillip Casselli
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $46.0M |
|---|---|
Revenue (TTM) | $22.4M |
Shares Outstanding | 137.4M |
Microbix Biosystems Inc does not pay a dividend. | |
Beta | 0.25 |
EPS | $0.03 |
Book Value | $0.18 |
P/E Ratio | 11.8x |
Price/Sales (TTM) | 2.1 |
Price/Cash Flow (TTM) | 9.0x |
Operating Margin | 16.57% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
